iBio reports preclinical data on IBIO-610 Activin E antibody in obese NHPs
Go back to iBio reports preclinical data on IBIO-610 Activin E antibody in obese NHPs| IBIO, Inc. (NASDAQ: IBIO) | Delayed: 1.28 +0.03 (2.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.25 | 52 Week High | $0.80 | |||
| Open | $1.26 | 52 Week Low | $0.34 | |||
| Day High | $1.30 | P/E | N/A | |||
| Day Low | $1.24 | EPS | $-0.08 | |||
| Volume | 445,359 | |||||
